Cargando…
Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K
Parkinson's disease (PD) is pathologically characterized by the presence of Lewy bodies (LBs) in dopaminergic neurons of the substantia nigra. These intracellular inclusions are largely composed of misfolded α-synuclein (AS), a neuronal protein that is abundant in the vertebrate brain. Point mu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591419/ https://www.ncbi.nlm.nih.gov/pubmed/23505409 http://dx.doi.org/10.1371/journal.pone.0049750 |
_version_ | 1782262052918657024 |
---|---|
author | Lemkau, Luisel R. Comellas, Gemma Lee, Shin W. Rikardsen, Lars K. Woods, Wendy S. George, Julia M. Rienstra, Chad M. |
author_facet | Lemkau, Luisel R. Comellas, Gemma Lee, Shin W. Rikardsen, Lars K. Woods, Wendy S. George, Julia M. Rienstra, Chad M. |
author_sort | Lemkau, Luisel R. |
collection | PubMed |
description | Parkinson's disease (PD) is pathologically characterized by the presence of Lewy bodies (LBs) in dopaminergic neurons of the substantia nigra. These intracellular inclusions are largely composed of misfolded α-synuclein (AS), a neuronal protein that is abundant in the vertebrate brain. Point mutations in AS are associated with rare, early-onset forms of PD, although aggregation of the wild-type (WT) protein is observed in the more common sporadic forms of the disease. Here, we employed multidimensional solid-state NMR experiments to assess A53T and E46K mutant fibrils, in comparison to our recent description of WT AS fibrils. We made de novo chemical shift assignments for the mutants, and used these chemical shifts to empirically determine secondary structures. We observe significant perturbations in secondary structure throughout the fibril core for the E46K fibril, while the A53T fibril exhibits more localized perturbations near the mutation site. Overall, these results demonstrate that the secondary structure of A53T has some small differences from the WT and the secondary structure of E46K has significant differences, which may alter the overall structural arrangement of the fibrils. |
format | Online Article Text |
id | pubmed-3591419 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35914192013-03-15 Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K Lemkau, Luisel R. Comellas, Gemma Lee, Shin W. Rikardsen, Lars K. Woods, Wendy S. George, Julia M. Rienstra, Chad M. PLoS One Research Article Parkinson's disease (PD) is pathologically characterized by the presence of Lewy bodies (LBs) in dopaminergic neurons of the substantia nigra. These intracellular inclusions are largely composed of misfolded α-synuclein (AS), a neuronal protein that is abundant in the vertebrate brain. Point mutations in AS are associated with rare, early-onset forms of PD, although aggregation of the wild-type (WT) protein is observed in the more common sporadic forms of the disease. Here, we employed multidimensional solid-state NMR experiments to assess A53T and E46K mutant fibrils, in comparison to our recent description of WT AS fibrils. We made de novo chemical shift assignments for the mutants, and used these chemical shifts to empirically determine secondary structures. We observe significant perturbations in secondary structure throughout the fibril core for the E46K fibril, while the A53T fibril exhibits more localized perturbations near the mutation site. Overall, these results demonstrate that the secondary structure of A53T has some small differences from the WT and the secondary structure of E46K has significant differences, which may alter the overall structural arrangement of the fibrils. Public Library of Science 2013-03-07 /pmc/articles/PMC3591419/ /pubmed/23505409 http://dx.doi.org/10.1371/journal.pone.0049750 Text en © 2013 Lemkau et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Lemkau, Luisel R. Comellas, Gemma Lee, Shin W. Rikardsen, Lars K. Woods, Wendy S. George, Julia M. Rienstra, Chad M. Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K |
title | Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K |
title_full | Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K |
title_fullStr | Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K |
title_full_unstemmed | Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K |
title_short | Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K |
title_sort | site-specific perturbations of alpha-synuclein fibril structure by the parkinson's disease associated mutations a53t and e46k |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591419/ https://www.ncbi.nlm.nih.gov/pubmed/23505409 http://dx.doi.org/10.1371/journal.pone.0049750 |
work_keys_str_mv | AT lemkauluiselr sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k AT comellasgemma sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k AT leeshinw sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k AT rikardsenlarsk sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k AT woodswendys sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k AT georgejuliam sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k AT rienstrachadm sitespecificperturbationsofalphasynucleinfibrilstructurebytheparkinsonsdiseaseassociatedmutationsa53tande46k |